Pre-diabetes - RE.DOCTOR


RE.DOCTOR through its development of Non-Invasive Blood Glucose Monitoring (BGM) has engineered a pre-diabetes solution that is non-invasive, easily accessible, and low cost.

Diabetes and it’s related outcomes are expected to be a significant problem worldwide, with a projected 1 in 2 diabetic patients being undiagnosed by 2030.

The potential to vastly enhance chronic illness management such as Type 2 Diabetes Mellitus (T2DM) is still largely untapped.

By monitoring blood glucose levels, RE.DOCTOR provides the ability to pre-emptively identify individuals with pre-diabetes and potentially allow diabetics to dynamically manage their treatment for better blood glucose control.

RE.DOCTOR leverages the latest technological advancement in signal processing, PPG technologies, and artificial intelligence (AI) to assess the risk of impaired glucose regulation.

Inter-beat-interval data collection via the mobile phone app allows the AI model to compute the relevant digital biomarkers correlated with the symptoms of prediabetes or T2DM and display the risk of developing diabetes.

In 2021,

Approximately 537 million adults (20-79 years) are living with diabetes.

  • The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
  • 3 in 4 adults with diabetes live in low- and middle-income countries
  • Almost 1 in 2 (240 million) adults living with diabetes are undiagnosed
  • Diabetes caused 6.7 million deaths
  • Diabetes caused at least USD 966 billion dollars in health expenditure – 9% of total spending on adults
  • More than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes
  • 1 in 6 live births (21 million) are affected by diabetes during pregnancy
  • 541 million adults are at increased risk of developing type 2 diabetes


Pre-Diabetes facts & figures

LAST UPDATE: 09/12/2021

atlas 10e cover

The IDF Diabetes Atlas Tenth edition 2021 provides the latest figures, information and projections on diabetes worldwide.

Download the IDF Diabetes Atlas 10th Edition 2021 and other resources at

At present, type 1 diabetes cannot be prevented. The environmental pre-diabetes triggers that are thought to generate the process that results in the destruction of the body’s insulin-producing cells are still under investigation.

While there are a number of factors that influence the development of type 2 diabetes, it is evident that the most influential are lifestyle behaviours commonly associated with urbanization.

These include consumption of unhealthy foods and inactive lifestyles with sedentary behaviour. Studies from different parts of the world have established that lifestyle modification with physical activity and/or healthy diet can delay or prevent the onset of type 2 diabetes.

Modern lifestyles are characterised by physical inactivity and long sedentary periods. Community-based interventions can reach individuals and families through campaigns, education, social marketing and encourage physical activity both inside and outside school and the workplace. IDF recommends physical activity at least between three to five days a week, for a minimum of 30-45 minutes.

Taking a life course perspective is essential for preventing type 2 diabetes and its complications. Early in life, when eating and physical activity habits are established and when the long-term regulation of energy balance may be programmed, there is an especially critical window to prevent the development of overweight and reduce the risk of type 2 diabetes. Healthy lifestyles can improve health outcomes at later stages of life as well.

This study demonstrated that smartphone-measured PPG, analyzed with deep learning, can be used as a noninvasive digital biomarker of prevalent diabetes.

Get in touch for any kind of help and information

Call for help:

North America: +1-833-940-0061

Europe: +995-598-230-563

Mail us for information

Our solutions are not a replacement for a healthcare professional and our solution does not diagnose, prevent, provide any treatment for any form of illness or disease.